Cargando…

Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets

Candida glabrata is the second most common etiological cause of worldwide systemic candidiasis in adult patients. Genome analysis of 68 isolates from 8 hospitals across Scotland, together with 83 global isolates, revealed insights into the population genetics and evolution of C. glabrata. Clinical i...

Descripción completa

Detalles Bibliográficos
Autores principales: Helmstetter, Nicolas, Chybowska, Aleksandra D, Delaney, Christopher, Da Silva Dantas, Alessandra, Gifford, Hugh, Wacker, Theresa, Munro, Carol, Warris, Adilia, Jones, Brian, Cuomo, Christina A, Wilson, Duncan, Ramage, Gordon, Farrer, Rhys A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071574/
https://www.ncbi.nlm.nih.gov/pubmed/35199143
http://dx.doi.org/10.1093/genetics/iyac031
_version_ 1784700867159523328
author Helmstetter, Nicolas
Chybowska, Aleksandra D
Delaney, Christopher
Da Silva Dantas, Alessandra
Gifford, Hugh
Wacker, Theresa
Munro, Carol
Warris, Adilia
Jones, Brian
Cuomo, Christina A
Wilson, Duncan
Ramage, Gordon
Farrer, Rhys A
author_facet Helmstetter, Nicolas
Chybowska, Aleksandra D
Delaney, Christopher
Da Silva Dantas, Alessandra
Gifford, Hugh
Wacker, Theresa
Munro, Carol
Warris, Adilia
Jones, Brian
Cuomo, Christina A
Wilson, Duncan
Ramage, Gordon
Farrer, Rhys A
author_sort Helmstetter, Nicolas
collection PubMed
description Candida glabrata is the second most common etiological cause of worldwide systemic candidiasis in adult patients. Genome analysis of 68 isolates from 8 hospitals across Scotland, together with 83 global isolates, revealed insights into the population genetics and evolution of C. glabrata. Clinical isolates of C. glabrata from across Scotland are highly genetically diverse, including at least 19 separate sequence types that have been recovered previously in globally diverse locations, and 1 newly discovered sequence type. Several sequence types had evidence for ancestral recombination, suggesting transmission between distinct geographical regions has coincided with genetic exchange arising in new clades. Three isolates were missing MATα1, potentially representing a second mating type. Signatures of positive selection were identified in every sequence type including enrichment for epithelial adhesins thought to facilitate fungal adhesin to human epithelial cells. In patent microevolution was identified from 7 sets of recurrent cases of candidiasis, revealing an enrichment for nonsynonymous and frameshift indels in cell surface proteins. Microevolution within patients also affected epithelial adhesins genes, and several genes involved in drug resistance including the ergosterol synthesis gene ERG4 and the echinocandin target FKS1/2, the latter coinciding with a marked drop in fluconazole minimum inhibitory concentration. In addition to nuclear genome diversity, the C. glabrata mitochondrial genome was particularly diverse, with reduced conserved sequence and conserved protein-encoding genes in all nonreference ST15 isolates. Together, this study highlights the genetic diversity within the C. glabrata population that may impact virulence and drug resistance, and 2 major mechanisms generating this diversity: microevolution and genetic exchange/recombination.
format Online
Article
Text
id pubmed-9071574
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-90715742022-05-06 Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets Helmstetter, Nicolas Chybowska, Aleksandra D Delaney, Christopher Da Silva Dantas, Alessandra Gifford, Hugh Wacker, Theresa Munro, Carol Warris, Adilia Jones, Brian Cuomo, Christina A Wilson, Duncan Ramage, Gordon Farrer, Rhys A Genetics Investigation Candida glabrata is the second most common etiological cause of worldwide systemic candidiasis in adult patients. Genome analysis of 68 isolates from 8 hospitals across Scotland, together with 83 global isolates, revealed insights into the population genetics and evolution of C. glabrata. Clinical isolates of C. glabrata from across Scotland are highly genetically diverse, including at least 19 separate sequence types that have been recovered previously in globally diverse locations, and 1 newly discovered sequence type. Several sequence types had evidence for ancestral recombination, suggesting transmission between distinct geographical regions has coincided with genetic exchange arising in new clades. Three isolates were missing MATα1, potentially representing a second mating type. Signatures of positive selection were identified in every sequence type including enrichment for epithelial adhesins thought to facilitate fungal adhesin to human epithelial cells. In patent microevolution was identified from 7 sets of recurrent cases of candidiasis, revealing an enrichment for nonsynonymous and frameshift indels in cell surface proteins. Microevolution within patients also affected epithelial adhesins genes, and several genes involved in drug resistance including the ergosterol synthesis gene ERG4 and the echinocandin target FKS1/2, the latter coinciding with a marked drop in fluconazole minimum inhibitory concentration. In addition to nuclear genome diversity, the C. glabrata mitochondrial genome was particularly diverse, with reduced conserved sequence and conserved protein-encoding genes in all nonreference ST15 isolates. Together, this study highlights the genetic diversity within the C. glabrata population that may impact virulence and drug resistance, and 2 major mechanisms generating this diversity: microevolution and genetic exchange/recombination. Oxford University Press 2022-02-23 /pmc/articles/PMC9071574/ /pubmed/35199143 http://dx.doi.org/10.1093/genetics/iyac031 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Genetics Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Investigation
Helmstetter, Nicolas
Chybowska, Aleksandra D
Delaney, Christopher
Da Silva Dantas, Alessandra
Gifford, Hugh
Wacker, Theresa
Munro, Carol
Warris, Adilia
Jones, Brian
Cuomo, Christina A
Wilson, Duncan
Ramage, Gordon
Farrer, Rhys A
Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets
title Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets
title_full Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets
title_fullStr Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets
title_full_unstemmed Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets
title_short Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets
title_sort population genetics and microevolution of clinical candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets
topic Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071574/
https://www.ncbi.nlm.nih.gov/pubmed/35199143
http://dx.doi.org/10.1093/genetics/iyac031
work_keys_str_mv AT helmstetternicolas populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT chybowskaaleksandrad populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT delaneychristopher populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT dasilvadantasalessandra populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT giffordhugh populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT wackertheresa populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT munrocarol populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT warrisadilia populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT jonesbrian populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT cuomochristinaa populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT wilsonduncan populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT ramagegordon populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets
AT farrerrhysa populationgeneticsandmicroevolutionofclinicalcandidaglabratarevealsrecombinantsequencetypesandhypervariationwithinmitochondrialgenomesvirulencegenesanddrugtargets